tiprankstipranks
Taysha Gene Therapies (TSHA)
NASDAQ:TSHA
US Market
Holding TSHA?
Track your performance easily

Taysha Gene Therapies (TSHA) Ownership - Who Owns Taysha Gene Therapies?

849 Followers

Taysha Gene Therapies (TSHA) Ownership Overview

20.12%11.08%54.79%14.00%
20.12% Insiders
54.79% Other Institutional Investors
― ETFs
14.00% Public Companies and Individual Investors
The ownership structure of Taysha Gene Therapies (TSHA) stock is a mix of institutional, retail, and individual investors. , 20.12% is owned by Insiders, and 14.00% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Jul 01, 2024
Paul B Manning
>10% Owner
xxxxxxxxxxxxx
$2999999
Nov 20, 2023
Paul B Manning
>10% Owner
xxxxxxxxxxxxx
$163000

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$2298842

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
10,872,503Institution5.31%23,375,881
7,692,583Institution3.75%16,539,053
7,557,108Institution3.69%16,247,782
7,494,251Institution3.66%16,112,640
6,931,384Institution3.38%14,902,476
6,003,152Institution2.93%12,906,777
5,937,641Institution2.90%12,765,928
4,004,756Institution1.95%8,610,225
1,125,709Institution0.55%2,420,274
1,026,269Institution0.50%2,206,478

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
7,692,583Institution3.75%16,539,053
6,003,152Institution2.93%12,906,777
5,937,641Institution2.90%12,765,928
1,125,709Institution0.55%2,420,274
934,125Institution0.46%2,008,369
256,124Institution0.12%550,667
243,880Institution0.12%524,342
150,700Institution0.07%324,005
92,210Institution0.04%198,252
88,081Institution0.04%189,374

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
4,456,319Institution2.17%9,848,465
4,326,141Institution2.11%9,301,203
2,469,279Institution1.20%5,407,721
2,469,279Institution1.20%5,407,721
2,469,279Institution1.20%5,407,721
1,481,322Institution0.72%3,273,722
1,415,059Institution0.69%3,042,377
1,003,895Institution0.49%2,158,374
628,225Institution0.31%1,388,377
371,426Institution0.18%798,566

FAQ

Who Owns Taysha Gene Therapies (TSHA)?
According to the latest TipRanks data, approximately 54.79% of the company's stock is held by institutional investors, 20.12% is held by insiders, and 14.00% is held by retail investors.
    What percentage of Taysha Gene Therapies (TSHA) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 54.79% of Taysha Gene Therapies (TSHA) stock is held by institutional investors.
      What percentage of Taysha Gene Therapies (TSHA) stock is held by retail investors?
      According to the latest TipRanks data, approximately 14.00% of Taysha Gene Therapies (TSHA) stock is held by retail investors.
        Who owns the most shares of Taysha Gene Therapies (TSHA)?
        Peter Kolchinsky owns the most shares of Taysha Gene Therapies (TSHA).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis